A stool test in patients with active ulcerative colitis helps exclude cytomegalovirus disease

References

• Rahier JF, Magro F, Abreu C, et al., European Crohn's and Colitis Organisation (ECCO). Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8(6):443–468.
   PubMed Web of Science ®Google Scholar
• Kishore J, Ghoshal U, Ghoshal UC, et al. Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome. J Med Microbiol. 2004;53(11):1155–1160.
   PubMed Web of Science ®Google Scholar
• Al-Zafiri R, Gologan A, Galiatsatos P, et al. Cytomegalovirus complicating inflammatory bowel disease: a 10-year experience in a community-based, university-affiliated hospital. Gastroenterol Hepatol (NY). 2012;8:230–239.
   PubMedGoogle Scholar
• Inokuchi T, Kato J, Hiraoka S, et al. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status. World J Gastroenterol. 2014;20(2):509–517.
   PubMed Web of Science ®Google Scholar
• Delvincourt M, Lopez A, Pillet S, et al. The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease. Aliment Pharmacol Ther. 2014;39(7):712–720.
   PubMed Web of Science ®Google Scholar
• Kuwabara A, Okamoto H, Suda T, et al. Clinicopathologic characteristics of clinically relevant cytomegalovirus infection in inflammatory bowel disease. J Gastroenterol. 2007;42(10):823–829.
   PubMed Web of Science ®Google Scholar
• Zagorowicz E, Bugajski M, Wieszczy P, et al. Cytomegalovirus infection in ulcerative colitis is related to severe inflammation and a high count of cytomegalovirus-positive cells in biopsy is a risk factor for colectomy. J Crohns Colitis. 2016;10(10):1205–1211.
   PubMed Web of Science ®Google Scholar
• Lee H-S, Park SH, Kim S-H, et al. Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis. Inflamm Bowel Dis. 2016;22(4):912–918.
   PubMed Web of Science ®Google Scholar
• Kojima T, Watanabe T, Hata K, et al. Cytomegalovirus infection in ulcerative colitis. Scand J Gastroenterol. 2006;41(6):706–711.
   PubMed Web of Science ®Google Scholar
• Clos-Parals A, Rodriguez-Martinez P, Canete F, et al. Prognostic value of the burden of cytomegalovirus colonic reactivation evaluated by immunohistochemical staining in patients with active ulcerative colitis. J Crohns Colitis. 2019;13(3):385–388.
   PubMed Web of Science ®Google Scholar
• Oh SJ, Lee CK, Kim YW, et al. True cytomegalovirus colitis is a poor prognostic indicator in patients with ulcerative colitis flares: the 10-year experience of an academic referral inflammatory bowel disease center. Scand J Gastroenterol. 2019;34:393–400.
   Google Scholar
• Schenk W, Klugmann T, Borkenhagen A, et al. The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic. Int J Colorectal Dis. 2019;34(3):393–400.
   PubMed Web of Science ®Google Scholar
• Beswick L, Ye B, van Langenberg DR. Toward an algorithm for the diagnosis and management of CMV in patients with colitis. Inflamm Bowel Dis. 2016;22(12):2966–2976.
   PubMed Web of Science ®Google Scholar
• Kopylov U, Eliakim-Raz N, Szilagy A, et al. Antiviral therapy in cytomegalovirus-positive ulcerative colitis: a systematic review and meta-analysis. World J Gastroenterol. 2014;20(10):2695–2703.
   PubMed Web of Science ®Google Scholar
• Wu XW, Yang MF, Li N, et al. Unfavorable outcome of antiviral therapy in cytomegalovirus-positive ulcerative colitis may be due to inappropriate study inclusion in meta-analysis. World J Gastroenterol. 2015;21(5):1689–1690.
   PubMed Web of Science ®Google Scholar
• Shukla T, Singh S, Loftus EV, Jr, et al. Antiviral therapy in steroid-refractory ulcerative colitis with cytomegalovirus: systematic review and meta-analysis. Inflamm Bowel Dis. 2015;21(11):2718–2725.
   PubMed Web of Science ®Google Scholar
• Harbord M, Eliakim R, Bettenworth D, et al. European Crohn’s and Colitis Organisation [ECCO]. Crohn’s ftE, Organisation C. Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: Current management. J Crohns Colitis. 2017;11(7):769–784.
   PubMed Web of Science ®Google Scholar
• McCurdy JD, Enders FT, Jones A, et al. Detection of cytomegalovirus in patients with inflammatory bowel disease: where to biopsy and how many biopsies? Inflamm Bowel Dis. 2015;21(12):2833–2838.
   PubMed Web of Science ®Google Scholar
• Kambham N, Vij R, Cartwright CA, et al. Cytomegalovirus infection in steroid-refractory ulcerative colitis: a case-control study. Am J Surg Pathol. 2004;28(3):365–373.
   PubMed Web of Science ®Google Scholar
• Cottone M, Pietrosi G, Martorana G, et al. Prevalence of cytomegalovirus infection in severe refractory ulcerative and Crohn's colitis. Am J Gastroenterol. 2001;96(3):773–775.
   PubMed Web of Science ®Google Scholar
• Kim JJ, Simpson N, Klipfel N, et al. Cytomegalovirus infection in patients with active inflammatory bowel disease. Dig Dis Sci. 2010;55(4):1059–1065.
   PubMed Web of Science ®Google Scholar
• Matsuoka K, Iwao Y, Mori T, et al. Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients. Am J Gastroenterol. 2007;102(2):331–337.
   PubMed Web of Science ®Google Scholar
• Yoshino T, Nakase H, Ueno S, et al. Usefulness of quantitative real-time PCR assay for early detection of cytomegalovirus infection in patients with ulcerative colitis refractory to immunosuppressive therapies. Inflamm Bowel Dis. 2007;13(12):1516–1521.
   PubMed Web of Science ®Google Scholar
• Dimitroulia E, Spanakis N, Konstantinidou AE, et al. Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease. Inflamm Bowel Dis. 2006;12:879–884.
   PubMed Web of Science ®Google Scholar
• Roblin X, Pillet S, Oussalah A, et al. Cytomegalovirus load in inflamed intestinal tissue is predictive of resistance to immunosuppressive therapy in ulcerative colitis. Am J Gastroenterol. 2011;106(11):2001–2008.
   PubMed Web of Science ®Google Scholar
• Pillet S, Pozzetto B, Roblin X. Cytomegalovirus and ulcerative colitis: place of antiviral therapy. World J Gastroenterol. 2016;22(6):2030–2045.
   PubMed Web of Science ®Google Scholar
• Pillet S, Williet N, Pouvaret A, et al. Distribution of cytomegalovirus DNA load in the inflamed colon of ulcerative colitis patients. Am J Gastroenterol. 2016;111(3):439–441.
   PubMed Web of Science ®Google Scholar
• Zagorowicz E, Przybysz A, Szlak J, et al. Detection of cytomegalovirus by immunohistochemistry of colonic biopsies and quantitative blood polymerase chain reaction: evaluation of agreement in ulcerative colitis. Scand J Gastroenterol. 2018;53(4):435–441.
   PubMed Web of Science ®Google Scholar
• Chan KS, Yang CC, Chen CM, et al. Cytomegalovirus colitis in intensive care unit patients: difficulties in clinical diagnosis. J Crit Care. 2014;29:474 e471–476.
   PubMed Web of Science ®Google Scholar
• Ganzenmueller T, Kluba J, Becker JU, et al. Detection of cytomegalovirus (cmv) by real-time pcr in fecal samples for the non-invasive diagnosis of CMV intestinal disease. J Clin Virol. 2014;61(4):517–522.
   PubMed Web of Science ®Google Scholar
• Sun YQ, Xu LP, Han TT, et al. Detection of human cytomegalovirus (CMV) DNA in feces has limited value in predicting cmv enteritis in patients with intestinal graft-versus-host disease after allogeneic stem cell transplantation. Transpl Infect Dis. 2015;17(5):655–661.
   PubMed Web of Science ®Google Scholar
• Herfarth HH, Long MD, Rubinas TC, et al. Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot study. Dig Dis Sci. 2010;55(4):1053–1058.
   PubMed Web of Science ®Google Scholar
• Thorn M, Rorsman F, Ronnblom A, et al. Active cytomegalovirus infection diagnosed by real-time PCR in patients with inflammatory bowel disease: a prospective, controlled observational study. Scand J Gastroenterol. 2016;51(9):1075–1080.
   PubMed Web of Science ®Google Scholar
• Prachasitthisak N, Tanpowpong P, Lertudomphonwanit C, et al. Short article: stool cytomegalovirus polymerase chain reaction for the diagnosis of cytomegalovirus-related gastrointestinal disease. Eur J Gastroenterol Hepatol. 2017;29(9):1059–1063.
   PubMed Web of Science ®Google Scholar
• Romkens TE, Bulte GJ, Nissen LH, et al. Cytomegalovirus in inflammatory bowel disease: a systematic review. World J Gastroenterol. 2016;22(3):1321–1330.
   PubMed Web of Science ®Google Scholar
• Nahar S, Iraha A, Hokama A, et al. Evaluation of a multiplex pcr assay for detection of cytomegalovirus in stool samples from patients with ulcerative colitis. WJG. 2015;21(44):12667–12675.
   PubMed Web of Science ®Google Scholar